Comparative analysis of immunological changes following realgar and arsenic trioxide treatments in a murine model of myelodysplastic syndrome-Reference-Cited by-同舟云学术

Comparative analysis of immunological changes following realgar and arsenic trioxide treatments in a murine model of myelodysplastic syndrome

Published:2024-05-03 Issue:3 Volume:46 Page:408-416
ISSN:0892-3973
Container-title:Immunopharmacology and Immunotoxicology
language:en
Short-container-title:Immunopharmacology and Immunotoxicology

Author:

Tao Yuchen¹,Xue Tingting¹,Li Xiaodong²,Guo Runjie³,Wang Yanlu¹,Xu Hao¹,Hu Kexin¹,Dong Xiaojie¹,Wang Dongqin¹,Ren Jianye¹,Guan Yu¹,Lu Jiahui¹

Affiliation:

1. Department of Haematology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China

2. Department of Cardiovascular Physiology, Faculty of Medicine, Kagawa University, Kagawa, Japan

3. Innovation Research Institute of Traditional Chinese Medicine, Center for Drug Safety Evaluation and Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China

Funder

National Natural Science Foundation of China

Program of Shanghai Academic Research Leader

Shanghai Science Technology and Innovation Action Plan

Clinical Science and Technology Innovation Project of Shanghai Shenkang Hospital Development Center

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/08923973.2024.2344158

Reference34 articles.

1. Myelodysplastic Syndromes

2. New Approaches to Myelodysplastic Syndrome Treatment

3. Resistance to Hypomethylating Agents in Myelodysplastic Syndrome and Acute Myeloid Leukemia From Clinical Data and Molecular Mechanism

4. Molecular Targeted Therapy and Immunotherapy for Myelodysplastic Syndrome

5. Allogeneic stem cell transplantation for patients with myelodysplastic syndromes